Also interesting

UCB expands innovation footprint with new state-of-the-art gene therapy facility
UCB, a global biopharmaceutical company, today announced it will build an innovative and environmentally sustainable gene therapy process development and clinical manufacturing facility on their high-tech campus in Braine l’Alleud...

GMP certification for Exothera further extends its viral vector manufacturing capacity
Exothera achieves GMP certification and extends its facilities by a further 2,100 m² (22,600 ft²) production bringing the total capacity to 8,600 m² (92,570 ft²) for viral vector development and manufacturing...

Univercells builds two production plants in Jumet
The biotechnology company Univercells is setting up its subsidiary Exothera in Jumet, on the former site of the IT company Systemat, to offer complete development and manufacturing services for viral vectors for the development of vaccines and gene therapies...